These treatments are recommended in international and Danish guidelines and include: sodium-glucose cotransporter-2 (SGLT-2) inhibitors (recommended in people with T2D and CKD), glucagon-like peptide (GLP-1) receptor agonists (recommended for improving glycemic control in older guidelines and for slowing CKD progression in newer guidelines), or non-steroidal mineralocorticoid receptor antagonists (ns-MRAs [finerenone], recommended for people with T2D, normal serum potassium concentration, and urinary albumin-to-creatinine ratio (UACR) 30 mg/g despite RAAS inhibition) [12,13,14,15]

The good news is that its one of the easiest symptoms of menopause to treat, such as with: medications like flibanserin and local vaginal estrogen hormone therapy and testosterone therapy OTC products, including vaginal moisturizers and lubricants peptide PT-141, which is FDA approved as the injectable brand-name medication Vyleesi (bremelanotide) for premenopausal women who have HSDD not caused by a medical or mental health condition Jump Back to Main Peptides List Peptide Dos and Donts Theres a lot to learn about peptides, and research is still ongoing
Arur et al., 2011)
GLP-1 Custom Treatment Plans - See Pricing Below by Medication/Pharmacy (medication cost included) GLP-1 Custom Treatment Plans Variable Pricing (see custom-compounded options below) Custom GLP-1 Treatment Plans are intended for patients who have a need for custom dosing of GLP-1 medications
Rather than dissolving immediately upon contact with gastric fluid, the capsule protects its contents until reaching the small intestine